NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update
Provided By GlobeNewswire
Last update: Feb 26, 2025
-- EMA submission expected in 2H25 by partner Menarini --
-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025 --
Read more at globenewswire.comNASDAQ:NAMS (8/7/2025, 2:05:04 PM)
22.34
-1.28 (-5.42%)
NASDAQ:NAMSW (8/6/2025, 8:00:02 PM)
12
+1.34 (+12.57%)
Find more stocks in the Stock Screener
